# CACNA1A

## Overview
The CACNA1A gene encodes the alpha-1A subunit of the P/Q-type voltage-gated calcium channel, known as CaV2.1, which is integral to the function of the central nervous system. This transmembrane protein plays a pivotal role in mediating calcium ion influx into neurons, thereby facilitating neurotransmitter release at synapses. The proper functioning of these channels is crucial for synaptic transmission, neuronal survival, and the maintenance of normal thalamocortical circuitry, which is essential for cognitive processes and cerebellar development (Bavassano2017Bicistronic; Indelicato2021From). Mutations in CACNA1A are linked to several neurological disorders, including episodic ataxia type 2, familial hemiplegic migraine type 1, and spinocerebellar ataxia type 6, highlighting its clinical significance (Indelicato2021From; Damaj2015CACNA1A).

## Structure
The CACNA1A gene encodes the alpha-1A subunit of the voltage-gated calcium channel CaV2.1, which is crucial for neurotransmitter release in the central nervous system. The protein structure includes four homologous domains (DI-DIV), each containing six transmembrane segments (S1-S6). These segments form two functional modules: the voltage sensor (S1-S4) and the Ca2+-selective pore (S5-P loop-S6) (Li2022CACNA1A; MartínezMonseny2021CACNA1A).

The primary structure of the CACNA1A protein involves a sequence of amino acids, with specific mutations such as R1350Q, Y1385C, and V1396M located in the α1A subunit isoforms 2 and 3 (MartínezMonseny2021CACNA1A). The secondary structure includes the voltage-sensor modules and the Ca2+-selective pore modules, with the S4 helices being crucial for voltage sensing (MartínezMonseny2021CACNA1A).

The tertiary structure is modeled using the α1S subunit of the CaV1.1 channel, highlighting the high level of homology between the rabbit CaV1.1 and human CaV2.1 channels (MartínezMonseny2021CACNA1A). The quaternary structure involves the assembly of the α1A subunit with regulatory subunits, including an α2δ dimer and one or more β subunits, forming the complete channel complex (Indelicato2021From). Splice variants result in different isoforms with distinct functional properties (Indelicato2021From).

## Function
The CACNA1A gene encodes the alpha-1A subunit of the P/Q-type voltage-gated calcium channels, which are crucial for calcium ion transport in neurons. These channels play a significant role in neurotransmitter release at synapses, particularly in cerebellar granules and Purkinje cells, and are essential for proper synaptic function and development (Bavassano2017Bicistronic; Indelicato2021From). The alpha-1A subunit determines the ion-specificity and kinetic properties of the channel, influencing synaptic plasticity and other regulatory processes in the central nervous system (Indelicato2021From).

In healthy human cells, the CACNA1A gene is responsible for the expression of the transmembrane alpha-1A subunit of the CaV2.1 voltage-gated calcium channel and the soluble alpha-1ACT transcription factor. The alpha-1ACT protein functions as a transcription factor that activates genes important for neuronal survival, such as BTG1, GRN, and TAF1 (Bavassano2017Bicistronic). The proper functioning of these channels is essential for maintaining normal thalamocortical circuitry, which is important for preventing disorders such as epilepsy (Indelicato2021From). The channels are also involved in cognitive processes, including memory and spatial learning, as well as in the maturation of the cerebellum (Indelicato2021From).

## Clinical Significance
Mutations in the CACNA1A gene are associated with a range of neurological disorders due to its role in encoding the alpha1 subunit of the P/Q-type voltage-gated calcium channel. These disorders include episodic ataxia type 2 (EA2), familial hemiplegic migraine type 1 (FHM1), and spinocerebellar ataxia type 6 (SCA6) (Indelicato2021From; Damaj2015CACNA1A; Sintas2017Mutation). EA2 is characterized by episodes of ataxia and nystagmus, often triggered by exertion or stress, and may respond to treatments like acetazolamide (Lipman2022Clinical; Damaj2015CACNA1A). FHM1 involves migraine attacks with motor symptoms such as hemiparesis (Battistini1999A; Indelicato2021From). SCA6 presents as a progressive cerebellar ataxia (Indelicato2021From).

CACNA1A mutations are also linked to epilepsy and developmental disorders. Loss-of-function mutations can lead to cognitive impairments, autism spectrum disorder, and epileptic encephalopathy (Li2022CACNA1A; Damaj2015CACNA1A). Specific variants, such as S218L, have been associated with severe impacts on calcium channel function, contributing to both FHM1 and epileptic encephalopathy (Indelicato2021From). The gene's mutations can result in either gain-of-function or loss-of-function effects, affecting neuronal signaling and leading to a wide phenotypic spectrum (IzquierdoSerra2020Rare; Indelicato2021From).

## Interactions
The CACNA1A gene encodes the α1A subunit of the P/Q-type voltage-gated calcium channel, which interacts with various synaptic proteins crucial for neurotransmitter release. One significant interaction involves SNARE proteins, including syntaxin 1A and SNAP-25, which bind to a synaptic protein interaction site (synprint) located within the intracellular loop between domains II and III of the α1A subunit. This interaction is essential for synaptic transmission, as it facilitates the docking and fusion of synaptic vesicles near the calcium entry pathway, optimizing neurotransmitter release (Zhong1999Reciprocal; Weiss2012Regulation).

The A454T mutation in CACNA1A disrupts these interactions, impairing the modulation of P/Q channels by SNARE proteins and reducing exocytosis efficiency. This mutation weakens the regulation of voltage-dependent steady-state inactivation by CaVβ subunits and suppresses P/Q channel modulation by SNARE proteins, leading to decreased neurotransmitter release (Serra2010A).

Additionally, synaptotagmin-1 interacts with the synprint site of CaV2.1 channels, reducing syntaxin-1A-dependent inhibition, while Cysteine String Proteins (CSP) promote presynaptic Ca2+ influx by recruiting dormant Ca2+ channels (Weiss2012Regulation). These interactions highlight the complex regulatory network involving CACNA1A in synaptic transmission.


## References


[1. (Indelicato2021From) Elisabetta Indelicato and Sylvia Boesch. From genotype to phenotype: expanding the clinical spectrum of cacna1a variants in the era of next generation sequencing. Frontiers in Neurology, March 2021. URL: http://dx.doi.org/10.3389/fneur.2021.639994, doi:10.3389/fneur.2021.639994. This article has 58 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fneur.2021.639994)

[2. (Damaj2015CACNA1A) Lena Damaj, Alexis Lupien-Meilleur, Anne Lortie, Émilie Riou, Luis H Ospina, Louise Gagnon, Catherine Vanasse, and Elsa Rossignol. Cacna1a haploinsufficiency causes cognitive impairment, autism and epileptic encephalopathy with mild cerebellar symptoms. European Journal of Human Genetics, 23(11):1505–1512, March 2015. URL: http://dx.doi.org/10.1038/ejhg.2015.21, doi:10.1038/ejhg.2015.21. This article has 156 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/ejhg.2015.21)

[3. (MartínezMonseny2021CACNA1A) Antonio F. Martínez-Monseny, Albert Edo, Dídac Casas-Alba, Mercè Izquierdo-Serra, Mercè Bolasell, David Conejo, Loreto Martorell, Jordi Muchart, Laura Carrera, Carlos I. Ortez, Andrés Nascimento, Baldo Oliva, José M. Fernández-Fernández, and Mercedes Serrano. Cacna1a mutations causing early onset ataxia: profiling clinical, dysmorphic and structural-functional findings. International Journal of Molecular Sciences, 22(10):5180, May 2021. URL: http://dx.doi.org/10.3390/ijms22105180, doi:10.3390/ijms22105180. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms22105180)

[4. (Bavassano2017Bicistronic) Carlo Bavassano, Andreas Eigentler, Ruslan Stanika, Gerald J. Obermair, Sylvia Boesch, Georg Dechant, and Roxana Nat. Bicistronic cacna1a gene expression in neurons derived from spinocerebellar ataxia type 6 patient-induced pluripotent stem cells. Stem Cells and Development, 26(22):1612–1625, November 2017. URL: http://dx.doi.org/10.1089/SCD.2017.0085, doi:10.1089/scd.2017.0085. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1089/SCD.2017.0085)

[5. (Lipman2022Clinical) Amy R. Lipman, Xiao Fan, Yufeng Shen, and Wendy K. Chung. Clinical and genetic characterization of <scp>cacna1a</scp>‐related disease. Clinical Genetics, 102(4):288–295, June 2022. URL: http://dx.doi.org/10.1111/cge.14180, doi:10.1111/cge.14180. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/cge.14180)

[6. (Zhong1999Reciprocal) Huijun Zhong, Charles T. Yokoyama, Todd Scheuer, and William A. Catterall. Reciprocal regulation of p/q-type ca2+ channels by snap-25, syntaxin and synaptotagmin. Nature Neuroscience, 2(11):939–941, November 1999. URL: http://dx.doi.org/10.1038/14721, doi:10.1038/14721. This article has 130 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/14721)

[7. (Weiss2012Regulation) Norbert Weiss and Gerald W. Zamponi. Regulation of Voltage-Gated Calcium Channels by Synaptic Proteins, pages 759–775. Springer Netherlands, 2012. URL: http://dx.doi.org/10.1007/978-94-007-2888-2_33, doi:10.1007/978-94-007-2888-2_33. This article has 19 citations.](https://doi.org/10.1007/978-94-007-2888-2_33)

[8. (Serra2010A) Selma A. Serra, Ester Cuenca-León, Artur Llobet, Francisca Rubio-Moscardo, Cristina Plata, Oriel Carreño, Noèlia Fernàndez-Castillo, Roser Corominas, Miguel A. Valverde, Alfons Macaya, Bru Cormand, and José M. Fernández-Fernández. A mutation in the first intracellular loop of cacna1a prevents p/q channel modulation by snare proteins and lowers exocytosis. Proceedings of the National Academy of Sciences, 107(4):1672–1677, January 2010. URL: http://dx.doi.org/10.1073/pnas.0908359107, doi:10.1073/pnas.0908359107. This article has 22 citations.](https://doi.org/10.1073/pnas.0908359107)

[9. (Li2022CACNA1A) Xue-Lian Li, Zong-Jun Li, Xiao-Yu Liang, De-Tian Liu, Mi Jiang, Liang-Di Gao, Huan Li, Xue-Qing Tang, Yi-Wu Shi, Bing-Mei Li, Na He, Bin Li, Wen-Jun Bian, Yong-Hong Yi, Chuan-Fang Cheng, and Jie Wang. Cacna1a mutations associated with epilepsies and their molecular sub-regional implications. Frontiers in Molecular Neuroscience, May 2022. URL: http://dx.doi.org/10.3389/fnmol.2022.860662, doi:10.3389/fnmol.2022.860662. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2022.860662)

[10. (Battistini1999A) S. Battistini, S. Stenirri, M. Piatti, C. Gelfi, P.G. Righetti, R. Rocchi, F. Giannini, N. Battistini, G.C. Guazzi, M. Ferrari, and P. Carrera. A new cacna1a gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia. Neurology, 53(1):38–38, July 1999. URL: http://dx.doi.org/10.1212/wnl.53.1.38, doi:10.1212/wnl.53.1.38. This article has 140 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1212/wnl.53.1.38)

[11. (IzquierdoSerra2020Rare) Mercè Izquierdo-Serra, José M. Fernández-Fernández, and Mercedes Serrano. Rare cacna1a mutations leading to congenital ataxia. Pflügers Archiv - European Journal of Physiology, 472(7):791–809, May 2020. URL: http://dx.doi.org/10.1007/s00424-020-02396-z, doi:10.1007/s00424-020-02396-z. This article has 22 citations.](https://doi.org/10.1007/s00424-020-02396-z)

[12. (Sintas2017Mutation) Cèlia Sintas, Oriel Carreño, Noèlia Fernàndez-Castillo, Roser Corominas, Marta Vila-Pueyo, Claudio Toma, Ester Cuenca-León, Isabel Barroeta, Carles Roig, Víctor Volpini, Alfons Macaya, and Bru Cormand. Mutation spectrum in the cacna1a gene in 49 patients with episodic ataxia. Scientific Reports, May 2017. URL: http://dx.doi.org/10.1038/s41598-017-02554-x, doi:10.1038/s41598-017-02554-x. This article has 34 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-017-02554-x)